From [HERE] The mRNA “vaccines” were released globally in early 2021 with the slogan ‘safe and effective.’ Unusually for a new class of medicine, they were soon recommended by public health authorities for pregnant women. 

Recently, a lengthy vaccine evaluation report sponsored by Pfizer and submitted to the Australian regulator (TGA) dated January 2021 was released under a Freedom of Information request. 

The report contains significant new information that had been suppressed by the TGA and by Pfizer itself. Much of this relates directly to the issue of safety in pregnancy, and impacts on the fertility of women of child-bearing age:

1. The “vaccine” travels throughout the body after injection, and is found not only at the injection site, but in all organs tested, with high concentration in the ovaries, liver, adrenal glands, and spleen.

Authorities who assured vaccinated people in early 2021 that the vaccine stays in the arm were, as we have known for two years, lying. 

2. A doubling of pregnancy loss in the intervention group represents a serious safety signal. 

Rather than take this seriously, the authors of the report compared the outcomes to historical data and ignored the outcome because other populations had recorded higher overall losses. This analysis is alarming as remaining below the highest previously recorded pregnancy loss levels in populations elsewhere is not a safe outcome when the intervention is also associated with double the harm of the control group.

3. There were higher rates of fetal malformations in each of the 12 categories studied. Of the 11 categories where Pfizer confirmed the data is correct, there are only 2 total abnormalities in the control group, versus 28 with the mRNA vaccine (BNT162b2). In the category which Pfizer labelled as unreliable, there were 3 abnormalities in the control group and 12 in the vaccinated group.

As with the increased pregnancy losses, Pfizer simply ignored the trend and compared the results with historical data. This is very significant as it is seen across every malformation category. The case control nature of the study design is again ignored, in order to apparently hide the negative outcomes demonstrated.

These data indicate that there is NO basis for saying the vaccine is safe in pregnancy. Concentration of LNPs in ovaries, a doubled pregnancy loss rate, and raised fetal abnormality rate across all measured categories indicates that designating a safe-in-pregnancy label was contrary to available evidence. 

The data implies that not only was the Government’s “safe and effective” sloganeering not accurate, it was totally misleading with respect to the safety data available.

[MORE]